JPM 2023 Sutro.pdf

1、NON-CONFIDENTIALNON-CONFIDENTIAL40thAnnual J.P.MorganHealthcare ConferenceJanuary 2022Sutro Biopharma NASDAQ:STRONON-CONFIDENTIALForward Looking StatementsThis presentation and the accompanying oral presentation contain“forward-looking”statements that are based on our managements beliefs and assumpt

2、ions and on information currently available to management.Forward-looking statements include all statements other than statements of historical fact contained in this presentation,including information concerning our future financial performance,business plans and objectives,current and future clini

3、cal activities,timing and success of our ongoing and planned clinical trials and related data,updates and results of our clinical trials and related data,timing and success of our planned development activities,our ability to obtain and maintain regulatory approval,the potential therapeutic benefits

4、 and economic value of our product candidates,potential growth opportunities,financing plans,potential future milestone and royalty payments,competitive position,industry environment and potential market opportunities for the Companys product candidates.Forward-looking statements are subject to know

5、n and unknown risks,uncertainties,assumptions and other factors,including risks and uncertainties related to our cash forecasts,our and our collaborators ability to advance our product candidates,the receipt and timing of potential regulatory submissions,designations,approvals and commercialization

6、of product candidates,the timing and results of preclinical and clinical trials,and the expected impact of the COVID-19 pandemic on our operations.It is not possible for our management to predict all risks,nor can we assess the impact of all factors on our business or the extent to which any factor,